Increase your skills and enhance your credentials with Certara training for Phoenix PK/PD and modeling software. Our training courses are taught by our senior scientists with many years of experience in PK/PD data analysis and modeling. They discuss best practices and methods to achieve regulatory success. Join the biosimulation revolution.
To register and view a full list of our available training classes, please visit: www.certara.com/training<http://www.certara.com/training>. Register today! Intermediate PK/PD Modeling Methodology using Phoenix WinNonlin- Instructor: Nathan Teuscher May 16-19, 2016 Copenhagen, Denmark Intro to Phoenix WinNonlin: Focus on Phoenix Model Object - Instructor: Tom Jones May 19-20, 2016 Boston, MA Advanced Pharmacometrics PK/PD Modeling Workshop using Phoenix NLME at (PAGE Conference) 6-7 June 2016 Lisbon, Portugal Advanced Level Workshop on Pharmacokinetic - Pharmacodynamic Data Analysis - Instructor: Dan Weiner June 13-16, 2016 Princeton, NJ Intermediate PK/PD Modeling Methodology using Phoenix WinNonlin- Instructor: Dan Weiner July 18-21, 2016 San Francisco, CA Intro to Phoenix WinNonlin - Instructor: Tom Jones August 9-11, 2016 San Francisco, CA Register for more than one class to receive a 30% discount! Simply enter promo code "2ormore". (Discounts cannot be combined) Register early to receive our early bird discount of 20 percent. To register and view a full list of our available training classes, please visit: www.certara.com/training<http://www.certara.com/training>. Hope to see you there! Kind regards, Certara NOTICE: The information contained in this electronic mail message is intended only for the personal and confidential use of the designated recipient(s) named above. This message may be an attorney-client communication, may be protected by the work product doctrine, and may be subject to a protective order. As such, this message is privileged and confidential. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this message in error and that any review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by telephone and e-mail and destroy any and all copies of this message in your possession (whether hard copies or electronically stored copies). Thank you. buSp9xeMeKEbrUze
